PPARG and Shock: Previous studies have shown that an endogenous PPAR-gamma agonist, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), can reduce inflammation-induced neutrophil migration in mesenteric tissues [13] and attenuate liver injury after hemorrhagic shock in rat model [11,29].